6Davis S.Opinising ctrnical traial design for Proof of nearoprotection in acute is chemic clinical trial programe[J].Cerebrovasc Dis,2012,22(51):18-23.
2Tananka M,Otsuki M,Tsutomu T,et al.In vitro and in vivo activity of DR-3355,an optically active isomer of ofloxacin[J].J.Antimicrob chemother,1990(26):659-666.
3Hoshino K,sato K,Akahane K,et al.Significance of the methyl group on the oxazine ring of loxacin derivatives in the inhibition of bacterial and mammalian type Ⅱ topoisomerases[J].Antimicrob Agents Chemother,1991,35(2):309-312.